(Q38056643)

English

Lipids and HCV.

scientific article published on 31 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Lipids and HCV (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

0 references

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Daniel J Felmlee

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

M F Bassendine

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

R D G Neely

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

31 October 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Seminars in Immunopathology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

35

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

87-100

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

https://scigraph.springernature.com/pub.10.1007/s00281-012-0356-2

0 references

The physiological and molecular regulation of lipoprotein assembly and secretion

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Epidemiology of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Genetic diversity and evolution of hepatitis C virus--15 years on

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Redefining chronic viral infection

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV)

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

HCV and the hepatic lipid pathway as a potential treatment target

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Histopathology of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus core protein decreases lipid droplet turnover: a mechanism for core-induced steatosis

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Autophagy protects cells from HCV-induced defects in lipid metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

MicroRNAs in lipid metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Endocannabinoids and their role in fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Animal models in the study of hepatitis C virus-associated liver pathologies

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

HCV and HCC: clinical update and a review of HCC-associated viral mutations in the core gene

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Blood lipids of patients with chronic hepatitis: differences related to viral etiology.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus infection causes hypolipidemia regardless of hepatic damage or nutritional state: An epidemiological survey of a large Japanese cohort

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Acute hepatitis C infection lowers serum lipid levels

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hypobetalipoproteinaemia secondary to chronic hepatitis C virus infection in a patient with familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivity

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C pharmacogenetics: state of the art in 2010.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Genotype rs8099917 near the IL28B gene and amino acid substitution at position 70 in the core region of the hepatitis C virus are determinants of serum apolipoprotein B-100 concentration in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Predictors of response of US veterans to treatment for the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirin

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus infection and the risk of coronary disease

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Insulin resistance and hepatitis C: an evolving story

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Apolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Lipid droplets as dynamic organelles connecting storage and efflux of lipids

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Apolipoprotein B is conformationally flexible but anchored at a triolein/water interface: a possible model for lipoprotein surfaces

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

High density lipoprotein structure-function and role in reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus and host cell lipids: an intimate connection

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus Replication

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type IIIalpha and regulates viral propagation

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Anti-HCV activities of selective polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Silencing of microRNAs in vivo with 'antagomirs'

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

The lipid droplet is an important organelle for hepatitis C virus production

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Maturation of hepatitis C virus core protein by signal peptide peptidase is required for virus production

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Trafficking of hepatitis C virus core protein during virus particle assembly

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus: assembly and release of virus particles

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Molecular determinants and dynamics of hepatitis C virus secretion

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

A genome-wide genetic screen for host factors required for hepatitis C virus propagation

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Mouse hepatic cells support assembly of infectious hepatitis C virus particles

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Characterization of hepatitis C RNA-containing particles from human liver by density and size

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Metabolomic profile of hepatitis C virus-infected hepatocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

A critical role for the chimpanzee model in the study of hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Complete replication of hepatitis C virus in cell culture

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Apolipoprotein C1 Association with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Transmission of low-density hepatitis C viral particles during sexually transmitted acute resolving infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Activation of the TASK-2 channel after cell swelling is dependent on tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus entry and the tetraspanin CD81.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

A genetically humanized mouse model for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

The LDL receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Recent insights into factors affecting remnant lipoprotein uptake.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Scavenger receptor, Class B, Type I provides an alternative means for beta-VLDL uptake independent of the LDL receptor in tissue culture.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Profound differences of microRNA expression patterns in hepatocytes and hepatoma cell lines commonly used in hepatitis C virus studies

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Genetic background of hepatocyte cell lines: are in vitro hepatitis C virus research data reliable?

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Sulfated Homologues of Heparin Inhibit Hepatitis C Virus Entry into Mammalian Cells

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Low density lipoprotein receptor as a candidate receptor for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Role of low-density lipoprotein receptor in the hepatitis C virus life cycle

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Production and characterization of HCV particles from serum-free culture

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Targeting HCV entry for development of therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secretion

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0356-2

21 January 2018

Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between lipid accumulation and the cannabinoid system in Huh7 cells expressing HCV genes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative reactivity of remnant-like lipoprotein particles (RLP) and low-density lipoprotein (LDL) to LDL receptor and VLDL receptor: effect of a high-dose statin on VLDL receptor expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term reversal of hypocholesterolaemia in patients with chronic hepatitis C is related to sustained viral response and viral genotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cholesterol and chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23111699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00281-012-0356-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Dimensions Publication ID

0 references

release_j3f76kimcfd7barypt725a6r3u

1 reference

https://api.fatcat.wiki/v0/release/j3f76kimcfd7barypt725a6r3u

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111699%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38056643&oldid=1839418020"